ArticleAsia Pacific allergy2025
Clinical characteristics and biomarker screening for dry nose.
Article in Asia Pacific allergy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Validity and reliability of the total rating of eye, nasal, and dry-mouth (TREND) score.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dry nose (DN) can be commonly observed in rhinitis, which can be objectively diagnosed; but it is usually ignored. Objective: The present work focused on analyzing clinical features, selecting biomarkers, and exploring the pathogenesis of DN. Methods: The present prospective single-center study was carried out between July 1, 2023, and January 31, 2024. Consecutive patients with suspected rhinitis according to common symptoms, including rhinorrhea, nasal obstruction, itching, and sneezing, were recruited at the allergy-rhinology outpatient in our hospital. All subjects filled in the questionnaires during recruitment for recording demographic data. DN test devices were used to diagnose DN. Sponges were utilized for collecting nasal secretions, while serum-specific immunoglobulin levels were utilized to determine allergic status. Results: Totally 1,323 chronic rhinitis patients were recruited, which included those with allergic rhinitis, idiopathic rhinitis (IR), local allergic rhinitis, and nonallergic rhinitis with eosinophilia syndrome. Of these participants, 8.6% were diagnosed with DN. The percentage of patients with DN and smokers remarkably increased in IR group. According to Qinling-Huaihe Line, 106 patients with DN (93.0%) were from Northern China. The IL-6 content in DN group apparently increased. Conclusions: DN affects over 8% of patients with chronic rhinitis in China, most of whom are from Northern China. Most patients with DN smoke, accounting for the largest proportion of patients with IR. Mitogen-activated protein kinase pathways and associated cytokines are probably critical for the pathogenic mechanism underlying this nasal disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.